<DOC>
	<DOCNO>NCT00100659</DOCNO>
	<brief_summary>The purpose study determine safety efficacy peginterferon alfa-2a ( PEG-2a ) combination ribavirin ( RV ) PEG-2a alone treatment chronic hepatitis C virus ( CHC ) infection child . The purpose study also determine whether PEG-2a combination RV PEG-2a alone result long response rate child CHC .</brief_summary>
	<brief_title>PEDS-C : Pegylated Interferon +/- Ribavirin Children With Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Male female patient 518 year age enrollment ( yet reach 18th birthday screen ) . HCV viremia ( test ) present 2 test separate least 6 month . Chronic liver disease , indicated inflammation and/or fibrosis , consistent chronic hepatitis C infection liver biopsy obtain within past 24 month , assess qualified pathologist , consistent know liver disease normal . Compensated liver disease ( ChildPugh Grade A clinical classification ) Signed informed consent parent/legal guardian willingness parent/legal guardian abide requirement study . Hemoglobin value &gt; 11 g/dL female ; &gt; 12 g/dL male Normal thyroid stimulate hormone ( TSH ) Able swallow RV/placebo tablet Any prior treatment Interferon RV Receipt investigational drug &lt; 6 week prior first dose study drug Any systemic antiviral therapy &lt; 6 week prior first dose study drug . Exception : patient take expected require acyclovir herpetic lesion Positive test screen antiHAV IgM Ab , HBsAg , antiHBc IgM Ab , antiHIV Ab History evidence medical condition associate chronic liver disease HCV ( abnormal ceruloplasmin , alpha1antitrypsin , ANA &gt; 1:160 , SMA &gt; 1:80 , antiLKM antibody &gt; 60 unit ) ) History evidence bleed esophageal varix Decompensated liver disease ( e.g . conjugate bilirubin &gt; 1.5mg/dl , ascites , varix , ChildPugh Grade B C clinical classification ) History autoimmune immunologically mediate disease ( e.g . inflammatory bowel disease , idiopathic thrombocytopenic purpura , lupus erythematosus , autoimmune hemolytic anemia , scleroderma , severe psoriasis , clinical evidence rheumatoid arthritis ) Absolute neutrophil count &lt; 1500 cells/mm3 , hemoglobin &lt; 11 g/dL female &lt; 12 g/dL male , white blood count &gt; 17.5 x 109/L , platelet count &lt; 90,000/ mm3 Serum creatinine level &gt; 1.5 time upper limit normal age Major depression accord American Psychiatric Association , history severe psychiatric disorder , major psychosis , suicidal ideation and/or suicide attempt History evidence chronic pulmonary cardiac disease associate functional limitation History thyroid disease poorly control prescribed medication . Patients elevate thyroid stimulate hormone ( TSH ) concentration elevation antibody thyroid peroxidase clinical manifestation thyroid disease exclude Poorly control diabetes define glycosylated hemoglobin &gt; 8 % History solid organ bone marrow transplantation Evidence severe retinopathy Coagulopathy ( international normalize ratio &gt; 1.5 ) Evidence active suspect cancer history malignancy risk recurrence &gt; 20 % within 2 year . Hemoglobinopathy Hemophilia Severe retinopathy History evidence severe illness condition would make patient , opinion investigator , unsuitable study Sexually active female childbearing potential ( define age 10 year old ) sexually active men practice two form effective contraception treatment 6 month treatment conclude Females positive serum pregnancy test within 7 day initiation treatment breastfeed Males whose female partner pregnant Active substance abuse A sibling and/or child live household share primary caregiver enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>pediatric</keyword>
	<keyword>hepatitis</keyword>
	<keyword>child</keyword>
	<keyword>HCV</keyword>
	<keyword>PEG</keyword>
	<keyword>PEG-2a</keyword>
	<keyword>peginterferon alfa-2a</keyword>
	<keyword>Pegylated Interferon</keyword>
	<keyword>RV</keyword>
	<keyword>ribavirin</keyword>
	<keyword>Pegasys</keyword>
	<keyword>CHC</keyword>
	<keyword>chronic hepatitis C</keyword>
	<keyword>chronic hepatitis C virus</keyword>
	<keyword>hepatitis c</keyword>
	<keyword>pediatric hepatitis</keyword>
	<keyword>pediatric HCV</keyword>
</DOC>